Table 1

h5-HT1A receptor-mediated stimulation of [35S]GTPγ S binding: disruption by anti-Gαi1/3 antibodies

LigandEminEmaxpEC50HpEC50L% HighnHn
% %
5-HT
 Control100218  ± 129.09  ±  0.037.70  ±  0.0559  ±  30.72  ±  0.047
+ anti-Gαi1/3 87  ±  3181  ± 68.15  ±  0.05 1-a 0.91  ±  0.035
+anti-pERK107  ±  3221  ± 169.16  ±  0.047.81  ±  0.1655  ±  20.69  ±  0.053
Pindolol
 Control100137  ± 27.88  ±  0.051-a 1.16  ±  0.073
+ anti-Gαi1/3 82  ±  2101  ± 37.79  ±  0.321-a 0.98  ±  0.083
+anti-pERK97  ±  2133  ± 28.18  ±  0.171-a 0.78  ±  0.083

Membranes were preincubated either with buffer (control conditions) or with an antibody against Gαi1/3 subunits or against pERK. The full agonist 5-HT or the partial agonist pindolol and [35S]GTPγS were then added and incubated for a further 1 h before filtering the membranes and scintillation counting. Isotherms were analyzed by nonlinear regression. Emin values are the basal [35S]GTPγ S binding observed in the absence of ligand, and are expressed as a percentage of control basal values (100%). Emax values are the maximal observed stimulation (relative to control basal values = 100%). pEC50H and pEC50L are effective concentration values for the high and low potency components. %High values are the percentage of sites in the high-potency component, andn H is the slope of the isotherms. Data are expressed as mean ± S.E.M. of n independent determinations performed in triplicate. In the case of 5-HT, isotherms were biphasic (P < 0.05, F-test), except when preincubated with anti-Gαi1/3. Pindolol yielded monophasic isotherms in all cases. Anti-Gαi1/3, but not anti-pERK, antibodies reduced basal [35S]GTPγ S binding from control values.

    • 1-a pEC50 value (single site fit).